Replies to post #12285 on Momenta Pharmaceuticals, Inc. (MNTA)

[semi_infinite]

That chart doesn't tell me much. Copaxone is number 10. If you look at the top 9, they all show similar trends and comparisons, except for Humira. Could this be an effect of the ACA causing hospitals and pharms to better manage prescriptions and inventory?

My earlier question to you was answered in the slides provided by DD. Nrx is 52% so I think 40 mg uptake will remain close to current split.